Literature DB >> 23447487

Use of pulsed dye laser in the treatment of sulcus vocalis.

Chi Sang Hwang1, Hyun Jin Lee, Jong Gyun Ha, Chang Il Cho, Na Hyun Kim, Hyun Jun Hong, Hong-Shik Choi.   

Abstract

OBJECTIVE: The pulsed dye laser (PDL) has been shown to be effective in the treatment of hypertrophic scars and keloids in dermatology. On the basis of histopathologic similarities between sulcus vocalis and scar tissue and numerous reports on the treatment of laryngeal lesions, especially scar tissue, with PDL, we evaluated the efficacy of treating sulcus vocalis with PDL. We named this surgical procedure PDL glottoplasty. STUDY
DESIGN: Case series with planned data collection.
SETTING: A university-based, tertiary care medical center. SUBJECTS AND METHODS: This study was conducted on 25 patients diagnosed with sulcus vocalis by videostroboscopy at the Gangnam Severance Hospital Otorhinolaryngology Department between August 2006 and February 2012. Energy delivery was fixed at 0.75 Joules (J) per pulse, and each vocal fold was administered 60 to 110 pulses (average 72.5 pulses) during each procedure. Aerodynamic, stroboscopic, and acoustic voice analyses were performed pre- and postoperatively.
RESULTS: Although assessment was necessarily subjective, our study indicated that vocal folds showed decreased stiffness and improved mucosal wave properties after treatment, resulting in improved vibration and dysphonia. In the objective assessments, most patients who underwent PDL glottoplasty showed improvement in several postoperative voice analysis indices. The differences between preoperative and some postoperative voice parameter indices were statistically significant.
CONCLUSION: We found PDL glottoplasty to be beneficial in the treatment of sulcus vocalis. Objective measurements of voice quality and normalization of vocal fold vibration improved after PDL treatment in most cases. Our results warrant further studies with larger numbers of participants and longer follow-up periods.

Entities:  

Mesh:

Year:  2013        PMID: 23447487     DOI: 10.1177/0194599813479909

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

1.  Feasibility and Associated Limitations of Office-Based Laryngeal Surgery Using Carbon Dioxide Lasers.

Authors:  Hao-Chun Hu; Shu-Yi Lin; Yi-Ting Hung; Shyue-Yih Chang
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-05-01       Impact factor: 6.223

2.  Pathological sulcus vocalis: treatment approaches and voice outcomes in 36 patients.

Authors:  Beata Miaśkiewicz; Agata Szkiełkowska; Elżbieta Gos; Aleksandra Panasiewicz; Elżbieta Włodarczyk; Piotr H Skarżyński
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-28       Impact factor: 2.503

3.  Bilateral vocal fold injection with autologous fat in patients with vocal fold atrophy with or without sulcus.

Authors:  Emke M J M van den Broek; Bas J Heijnen; Martine Hendriksma; Vivienne A H van de Kamp-Lam; Antonius P M Langeveld; Peter Paul G van Benthem; Elisabeth V Sjögren
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-27       Impact factor: 2.503

4.  Treatment of Hemorrhagic Vocal Polyps by Pulsed Dye Laser-Assisted Laryngomicrosurgery.

Authors:  Hyung Kwon Byeon; Ji Hyuk Han; Byeong Il Choi; Hye Jin Hwang; Ji-Hoon Kim; Hong-Shik Choi
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

5.  Bilateral medialization thyroplasty in patients with vocal fold atrophy with or without sulcus.

Authors:  Emke M J M van den Broek; Bas J Heijnen; Martine Hendriksma; Vivienne A H van de Kamp-Lam; Thijs O Verhagen; Antonius P M Langeveld; Peter Paul G van Benthem; Elisabeth V Sjögren
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-02       Impact factor: 2.503

6.  Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes.

Authors:  Jae-Yol Lim; Young Min Park; Minsuk Kang; Seung Jin Lee; Kwangha Baek; Jina Na; Hong-Shik Choi
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.